Josh Osowicki
@joshosowicki.bsky.social
640 followers 1.2K following 97 posts
Posts Media Videos Starter Packs
Reposted by Josh Osowicki
fabysk.bsky.social
I am exciting to publish our validated, lab-based model of oral gonorrhoea infection! With this model we can begin to understand how gonorrhoea behaves in the mouth (which is lacking) and screen for new compounds for interventions such as a gum to prevent infections. sti.bmj.com/content/earl...
sti.bmj.com
Reposted by Josh Osowicki
nizet.bsky.social
Our new review “𝘛𝘩𝘦 𝘊𝘦𝘯𝘵𝘳𝘢𝘭 𝘐𝘮𝘱𝘰𝘳𝘵𝘢𝘯𝘤𝘦 𝘰𝘧 𝘝𝘢𝘤𝘤𝘪𝘯𝘦𝘴 𝘵𝘰 𝘔𝘪𝘵𝘪𝘨𝘢𝘵𝘦 𝘵𝘩𝘦 𝘛𝘩𝘳𝘦𝘢𝘵 𝘰𝘧 𝘈𝘯𝘵𝘪𝘣𝘪𝘰𝘵𝘪𝘤-𝘙𝘦𝘴𝘪𝘴𝘵𝘢𝘯𝘵 𝘉𝘢𝘤𝘵𝘦𝘳𝘪𝘢𝘭 𝘗𝘢𝘵𝘩𝘰𝘨𝘦𝘯𝘴” is out

Compared to antibiotics, vaccines:

✓ Act prophylactically at low pathogen burden

✓ Less prone to inducing resistance due to multifactorial nature of immune pressure

🧵1/3
joshosowicki.bsky.social
Some NICUs don’t specifically cover anaerobes for NEC, although more to do with understanding of the developing GI microbiome. Your Q isn’t whether anaerobes are there, more what happens if we don’t go out of our way to treat them? There are some cholangitis & asp pneumonia studies 🤷‍♂️
joshosowicki.bsky.social
🤔 could consider when clindamycin was abandoned for IAI (because rising Bacteroides-R). If this was preceded by ⬆️ refractory cases that would be convincing-ish. And how about before any of these drugs were available? Anaerobic culture standards probably haven’t been consistent enough to be useful.
Reposted by Josh Osowicki
drmichaelmarks.bsky.social
Exited to announce 2 EDCTP consortiums led @lshtm.bsky.social w partners in Europe & West, East & Southern Africa

MAMS4CL will deliver seamless Phase 2-3 trial of treatments for Cutaneous Leishmaniasis.

IVMKIDS will provide data on paediatric dosing ivermectin down to 5kg/weight for STH & Scabies.
Reposted by Josh Osowicki
drmichaelmarks.bsky.social
Phenomenal piece of work by a great team across @mrcunitgambia.bsky.social @lshtm.bsky.social @sheffielduni.bsky.social - Delighted to have played a small part in combining epidemiology & immunology to shed light on what protection for #StrepA might look like & help advance vaccine development.
alexjkeeley.bsky.social
🧵 Our paper out today in @naturemedicine.bsky.social

www.nature.com/articles/s41...

On development of #StrepA #Immunity over life course in #TheGambia raising hope for #vaccines on the horizon

1/

#Immunosky #IDsky #MicroSky #globalhealth.
www.nature.com
Reposted by Josh Osowicki
claireyt.bsky.social
Fantastic to see this immense body of excellent work published! Well done @alexjkeeley.bsky.social and everyone involved 👏

#StrepA
@floreyinstitute.bsky.social
@molmicrosheffield.bsky.social
alexjkeeley.bsky.social
🧵 Our paper out today in @naturemedicine.bsky.social

www.nature.com/articles/s41...

On development of #StrepA #Immunity over life course in #TheGambia raising hope for #vaccines on the horizon

1/

#Immunosky #IDsky #MicroSky #globalhealth.
www.nature.com
Reposted by Josh Osowicki
thushan-desilva.bsky.social
VERY excited by our latest work on StrepA below, but also rhe multiple collaborations and work to come off the back of this at MRCG
alexjkeeley.bsky.social
🧵 Our paper out today in @naturemedicine.bsky.social

www.nature.com/articles/s41...

On development of #StrepA #Immunity over life course in #TheGambia raising hope for #vaccines on the horizon

1/

#Immunosky #IDsky #MicroSky #globalhealth.
www.nature.com
Reposted by Josh Osowicki
alexjkeeley.bsky.social
🧵 Our paper out today in @naturemedicine.bsky.social

www.nature.com/articles/s41...

On development of #StrepA #Immunity over life course in #TheGambia raising hope for #vaccines on the horizon

1/

#Immunosky #IDsky #MicroSky #globalhealth.
www.nature.com
Reposted by Josh Osowicki
nizet.bsky.social
Congratulations to 𝐃𝐎𝐂𝐓𝐎𝐑 𝐃𝐀𝐍𝐈𝐄𝐋 𝐒𝐔𝐍 on the successful defense of his PhD "𝘊𝘰𝘯𝘴𝘪𝘥𝘦𝘳𝘪𝘯𝘨 𝘵𝘩𝘦 𝘏𝘰𝘴𝘵-𝘗𝘢𝘵𝘩𝘰𝘨𝘦𝘯 𝘐𝘯𝘵𝘦𝘳𝘧𝘢𝘤𝘦 𝘧𝘰𝘳 𝘕𝘰𝘷𝘦𝘭 𝘈𝘱𝘱𝘳𝘰𝘢𝘤𝘩𝘦𝘴 𝘵𝘰 𝘛𝘳𝘦𝘢𝘵 𝘋𝘳𝘶𝘨 𝘙𝘦𝘴𝘪𝘴𝘵𝘢𝘯𝘵 𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴" in the Biomedical Sciences Graduate Program as part of his dual degree training in the UCSD SSPPS PharmD/PhD Program
joshosowicki.bsky.social
Many, perhaps most, of the deaths from ‘nephropathies’ (8%) and heart disease (12%) would have been infection-related so >2/3 deaths likely infection-related. Many, probably most, due to APSGN & RHD (i.e. #StrepA). Guess what? 🇺🇸 made a vaccine (it worked). 🌏 needs to do it again.
Reposted by Josh Osowicki
joshosowicki.bsky.social
It becomes the Thesis of Theseus.
Reposted by Josh Osowicki
biainfection.bsky.social
Read the latest Journal of #Infection for the Phase-IIa trial and how it evaluates the safety and pharmacokinetics of high-dose, 10 weekly subcutaneous injections of penicillin (#SCIP) in young people with a history of acute rheumatic fever (#ARF) 👉 www.journalofinfecti...
Reposted by Josh Osowicki
nizet.bsky.social
🄰🅆🄴🅂🄾🄼🄴
Stubbusch et al 𝘚𝘊𝘐𝘌𝘕𝘊𝘌

Bacteria 🦠 repurpose Type VI Secretion Systems based on environmental cues:

Nutrient-rich environments ➜ kill competitors

Under starvation ➜ lyse neighbors to scavenge their nutrients

Even “non-pathogens” shift from competition to predation as a survival strategy
Antagonism as a foraging strategy in microbial communities
In natural habitats, nutrient availability limits bacterial growth. We discovered that bacteria can overcome this limitation by acquiring nutrients by lysing neighboring cells through contact-dependen...
www.science.org
Reposted by Josh Osowicki
sc345.bsky.social
Dr O Xie has an entertaining talk on S. dys subsp eq [SDSE]

🐴 iSDSE has similar incidence and mortality v iGAS
🐎 Less genomic clustering in SDSE
🫏 Global dissemination iSDSE driven by stG62647-lineage

#LISSSD25 #clinmicro #idsky